FB pixel

Imprivata, Symantec provide fingerprint identification solution for e-prescriptions

 

Imprivata has partnered with Symantec to provide a complete fingerprint biometric and FICAM-certified credential service provider (CSP) solution for the electronic prescribing of controlled substances (EPCS).

Symantec Norton Secure Login, which acts as the CSP, and Symantec Validation and ID Protection Services integrate with Imprivata Confirm ID to simplify the process of identity-proofing and authorizing prescribers to comply with DEA requirements for EPCS.

“Our strategic partnership with Symantec provides customers with a complete, DEA-compliant solution for identity-proofing individual prescribers to help meet regulatory requirements for EPCS,” said David Ting, CTO at Imprivata. “The integrated solution gives administrators a single workflow for enabling the use of Symantec one-time password tokens and/or Imprivata’s fingerprint biometric identification for EPCS. This gives hospitals greater flexibility in matching the best two-factor authentication option to fit their prescribers’ clinical workflow requirements.”

The DEA states that all individual prescribers must obtain two-factor authentication data from a GSA-approved CSP such as Symantec.

The combined Imprivata-Symantec solution gives providers a single solution for performing identity-proofing and credentialing tasks, enabling them to use OTP tokens and/or fingerprint biometric identification to fulfill two-factor authentication requirements for EPCS.

Imprivata Confirm ID offers identity-proofing, supervised enrollment of providers’ approved credentials, support for multiple DEA-approved two-factor authentication modalities for prescription signing, and a range of auditing and reporting tools.

The solution also simplifies EPCS by integrating directly into the e-prescribing workflows of EHRs and enabling providers to use the approved two-factor authentication credential options that meet their e-prescribing workflow requirements.

This ultimately improves efficiency and provider satisfaction while maintaining security, which greatly reduces the chance of fraud or drug diversion.

Article Topics

 |   |   |   | 

Latest Biometrics News

 

Ethiopia reveals strategy behind digital ID progress as ID4Africa 2025 opens

Ethiopia’s Fayda digital ID program successes were in the spotlight on the first day of ID4Africa 2025 in the country’s…

 

ID4Africa 2025 begins with record numbers, urgency and Ethiopian PM’s address

ID4Africa’s 2025 AGM kicked off today in Addis Ababa, Ethiopia, attended by Prime Minister Dr. Abiy Ahmed Ali and several…

 

Biometrics, age-appropriate design on the mind of UK Information Commissioner

UK Information Commissioner John Edwards is on a bit of a speaking tour, having recently addressed Privacy New Zealand –…

 

Simprints highlights Gavi support for privacy-first biometrics for vaccines program in Ghana

Simprints welcomed Gavi CEO Dr. Sania Nishtar on a visit to Ghana to observe pioneering vaccine delivery that utilizes biometrics….

 

Prevalence of fraud-as-a-service models eroding online trust at speed: Jumio

Digital trust is “crumbling” under an avalanche of synthetic media, misinformation and deepfake fraud, according to a new report from…

 

Digital Cooperation Organization wants Global South to join global digital policymaking

Pakistan has recently concluded the first Digital Foreign Direct Investment Forum 2025 (DFDI) in preparation for taking over the presidency…

Comments

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Biometric Market Analysis

Most Viewed This Week

Featured Company

Biometrics Insight, Opinion

Digital ID In-Depth

Biometrics White Papers

Biometrics Events